The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 181-188 , January 2010

Effects of novel synthetic serine protease inhibitors on postoperative blood loss, coagulation parameters, and vascular relaxation after cardiac surgery

  • Gábor Szabó, MD, PhD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • Corresponding Author InformationAddress for reprints: Gábor Szabó, MD, PhD, Department of Cardiac Surgery, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
    • ,
  • Gábor Veres, MD

      Affiliations

    • Department of Cardiology, Angiology, and Pulmonology, University of Heidelberg, Heidelberg, Germany
    • ,
  • Tamás Radovits, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Humaira Haider, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Nelli Krieger, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Susanne Bährle, MD

      Affiliations

    • Department of Cardiovascular Surgery, Semmelweis University Medical School, Budapest, Hungary
    • ,
  • Christiane Miesel-Gröschel, MTA

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Silke Niklisch, MTA

      Affiliations

    • Curacyte Discovery GmbH, Leipzig, Germany
    • ,
  • Matthias Karck, MD

      Affiliations

    • Department of Cardiac Surgery, University of Heidelberg, Heidelberg, Germany
    • ,
  • Andreas van de Locht, PhD

      Affiliations

    • Curacyte Discovery GmbH, Leipzig, Germany

Received 8 May 2008 ,Revised 9 August 2009 ,Accepted 7 September 2009.

References 

  1. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, et al. Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg. 1998;133:442–447
  2. Keogh B, Kinsman R. Fifth national adult cardiac surgical database report 2003. Reading (UK): Dendrite Clinical Systems. 2004;
  3. Beierlein W, Scheule AM, Dietrich W, Ziemer G. Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg. 2005;79:741–748
  4. Dietrich W, Spath P, Zuhlsdorf M, Dalichau H, Kirchhoff PG, Kuppe H, et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology. 2001;95:64–71
  5. Katz BA, Sprengeler PA, Luong C, Verner E, Elrod K, Kirtley M, et al. Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chem Biol. 2001;8:1107–1121
  6. Alderman EL, Levy JH, Rich JB, Nili M, Vidne B, Schaff H, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg. 1998;116:716–730
  7. Kalkat A, Levine , Dunning J. Does use of aprotinin in coronary artery bypass graft surgery affect graft patency?. Interact Cardiovasc Thorac Surg. 2004;3:124–128
  8. Bidstrup BP, Underwood SR, Sapsford RN, Streets RM. Effect of aprotinin (Trasylol) on aorta-coronary bypass graft patency. J Thorac Cardiovasc Surg. 1993;105:147–152
  9. Khan TA, Bianchi C, Voisine O, Feng J, Baker J, Hart M, et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg. 2004;128:602–608
  10. Ülker S, Cinar MG, Bayraktutan U, Evinc A. Aprotinin impairs endothelium-dependent relaxation in rat aorta and inhibits nitric oxide release from rat coronary endothelial cells. Cardiovasc Res. 2001;50:589–596
  11. Ülker S, McKeown PP, Bayraktutan U. Aprotinin impairs coronary endothelial function and down-regulates endothelial NOS in rat coronary microvascular endothelial cells. Cardiovasc Res. 2002;55:830–837
  12. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Lundsgaard-Hansen P. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;101:958–967
  13. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet. 1987;2:1289–1291
  14. Murkin JM, Lux J, Shannon NA, Guiraudon GM, Menkis AH, McKenzie FN, et al. Aprotinin significantly decreases bleeding and transfusion requirements in patients receiving aspirin and undergoing cardiac operations. J Thorac Cardiovasc Surg. 1994;107:554–561
  15. Bittner HB, Lamke J, Lange M, Rastan A, Mohr FW. The impact of aprotinin on blood loss and blood transfusion in off pump coronary artery bypass grafting. Ann Thorac Surg. 2008;85:1662–1668
  16. Dietrich W, Nicklisch S, Koster A, Spannagl M, Giersiefen H, van de Locht A. CU-2010—a novel small molecule protease inhibitor with antifibrinolytic and anticoagulant properties. Anesthesiology. 2009;110:123–130
  17. Landis RC, Asimakopoulos G, Poullis M, Haskard DO, Taylor KM. The antithrombotic and antiinflammatory mechanisms of action of aprotinin. Ann Thorac Surg. 2001;72:2169–2175
  18. Khan TA, Bianchi C, Voisine P, Sandmeyer J, Feng J, Sellke FW. Aprotinin inhibits protease-dependent platelet aggregation and thrombosis. Ann Thorac Surg. 2005;79:1545–1550
  19. Despotis GJ, Filos KS, Levine V, Alsoufiev A, Spitznagel E. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro. Anesth Analg. 1996;82:1126–1131
  20. Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB. In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg. 1992;104:1135–1140
  21. Veres G, Radovits T, Schulz H, Linn LN, Hütter J, Weigang E, et al. Effect of recombinant aprotinin on postoperative blood loss and coronary vascular function in a canine model of cardiopulmonary bypass. Eur J Cardiothorac Surg. 2007;28:801–804
  22. Fischer JH, Steinhoff M. Effects of aprotinin on endothelium-dependent relaxation of large coronary arteries. Eur J Cardiothorac Surg. 2005;28:801–804
  23. Allen S, Anastasiou N, Royston D, Paniagua R, Yacoub M. Effect of aprotinin on vascular reactivity of coronary bypass grafts. J Thorac Cardiovasc Surg. 1997;113:319–326

 Read at the Eighty-eighth Annual Meeting of The American Association for Thoracic Surgery, San Diego, Calif, May 10–14, 2008.

 Disclosures: Andreas van de Locht is an employee of Curacyte GmbH; Gábor Szabó reports consulting fees and grant support for this study from Curacyte Ltd, the manufacturer of the analogues.

 Supported by research grant from Curacyte Discovery GmbH, Leipzig, Germany.

PII: S0022-5223(09)01199-4

doi: 10.1016/j.jtcvs.2009.09.019

The Journal of Thoracic and Cardiovascular Surgery
Volume 139, Issue 1 , Pages 181-188 , January 2010

Article Tools

* Image Usage & Resolution